| Perkembangan teknologi nanopartikel sebagai sistem penghantaran obat R Martien, A Adhyatmika, IDK Irianto, V Farida, DP Sari Majalah Farmaseutik 8 (1), 133-144, 2012 | 187* | 2012 |
| The elusive antifibrotic macrophage A Adhyatmika, KSS Putri, L Beljaars, BN Melgert Frontiers in medicine 2, 81, 2015 | 78 | 2015 |
| The role of osteoprotegerin (OPG) in fibrosis: its potential as a biomarker and/or biological target for the treatment of fibrotic diseases H Habibie, A Adhyatmika, D Schaafsma, BN Melgert Pharmacology & therapeutics 228, 107941, 2021 | 26 | 2021 |
| Osteoprotegerin is more than a possible serum marker in liver fibrosis: A study into its function in human and murine liver A Adhyatmika, L Beljaars, KSS Putri, H Habibie, CE Boorsma, ... Pharmaceutics 12 (5), 471, 2020 | 21 | 2020 |
| In vitro and ex vivo anti-fibrotic effects of LY2109761, a small molecule inhibitor against TGF-β T Luangmonkong, S Suriguga, A Adhyatmika, A Adlia, D Oosterhuis, ... Toxicology and Applied Pharmacology 355, 127-137, 2018 | 19 | 2018 |
| Osteoprotegerin expression in liver is induced by IL-13 through TGF-β A Adhyatmika, KSS Putri, E Gore, KA Mangnus, C Reker-Smit, ... Cellular Physiology & Biochemistry 56 (1), 28-38, 2022 | 7 | 2022 |
| The development of nanoparticle technology as a drug delivery system R Martien, A Adhyatmika, ID Irianto, V Farida, DP Sari Pharm Mag 8 (1), 133-144, 2012 | 6 | 2012 |
| V., & Sari, DP (2012) R Martien, I Adhyatmika, F IDK Technology Developments Nanoparticles as Drug. Majalah Farmaseutik 8 (1 …, 0 | 6 | |
| Perkembangan Teknologi Nanopartikel Sebagai Sistem Penghantar Obat M Ronny, I Adhyatmika, DK Iramie, V Farida, DP Sari Majalah Farmasetika 8 (1), 2012 | 5 | 2012 |
| Cytotoxic selectivity of MJCO. 3 and MJCo. s, acidic ribosome-inactivating proteins isolated from Mirabilis jalapa L. leaves against various cancer cell-lines MSH Sismindari, RSS Adhyatmika Journal of the Medical Sciences 42 (2010), 2010 | 4 | 2010 |
| Osteoprotegerin production and profibrotic activity in liver fibrosis are TGFβ dependent A Adhyatmika, KSS Putri, L Beljaars, E Gore, KA Mangnus, C Reker-Smit, ... Journal of Hepatology 1 (66), S147, 2017 | 3 | 2017 |
| Osteoprotegerin is more than a serum marker in liver fibrosis A Adhyatmika, L Beljaars, KSS Putri, C Reker-Smit, CE Boorsma, ... Journal of Hepatology 1 (66), S147-S148, 2017 | 2 | 2017 |
| Validation UV Spectrophotometric Method to Determine Entrapment Efficiency of Ocular Polymeric Nanoparticle Levofloxacin Hemihydrate I Maharini, R Martien, AK Nugroho Research Journal of Pharmacy and Technology 14 (10), 5479-5482, 2021 | 1 | 2021 |
| Osteoprotegerin in Fibrotic Disorders A Adhyatmika | 1 | 2018 |
| Nanoparticle Preparation of Pentagamavunon-0 Using Medium Viscous Chitosan Matrix Cross Linked by Sodium Tripolyphosphate Through Ionic Gelation Mechanism as Anti-Inflammatory … A Adhyatmika, R Martien, H Ismail Majalah Farmaseutik 13 (2), 65-78, 2017 | 1 | 2017 |
| Osteoprotegerin is an early marker of the fibrotic process and of antifibrotic treatment responses in ex vivo lung fibrosis KSS Putri, A Adhyatmika, CE Boorsma, H Habibie, MJR Ruigrok, ... Lung, 1-12, 2024 | | 2024 |
| Validation of Uv-Vis Spectrophotometric Method to Determine Drug Release of Quercetin Loaded-Nanoemulsion VS Putri, AN Ikhsan, R Martien, A Adhyatmika Indonesian Journal of Pharmacy, 2023 | | 2023 |
| Osteoprotegerin, RANKL and extracellular matrix intersection in fibrosis H Habibie | | 2022 |
| ID 33. Self Nano-Emulsifying Formulation for Gamavuton-0 with Improved Anti-Rheumatoid Arthritis Effectiveness In Vivo. L Chabib, IK Bagiana, Z Ikawati, R Martien, H Ismail, A Adhyatmika, ... Journal of Pharmacy & Bioallied Sciences 12, 2020 | | 2020 |
| Development of glibenclamide validation method using UV-Spectrophotometry for solubility test in mesoporous mannitol N Kusumorini, A Adhyatmika, SI Biruni, S Anugrahanti Majalah Farmaseutik 19 (3), 468-473, 0 | | |
Ronny MartienGadjah Mada UniversityVerified email at ugm.ac.id
